Durect Corp (DRRX) Dividend History

Company News

• DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

  DURECT Corporation, a late-stage biopharmaceutical company, will report its fourth quarter and full year 2024 financial results and provide a business update on March 26, 2025. The company is pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions, including acute organ injury.

  Benzinga
• Are Medical Stocks Lagging DURECT (DRRX) This Year?

  Here is how Durect (DRRX) and Elevance Health (ELV) have performed compared to their sector so far this year.

  Zacks Investment Research

  Featured Companies: ELV
• Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates

  Durect (DRRX) delivered earnings and revenue surprises of -19.05% and 33.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research
• Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue Estimates

  CARISMA THERAP (CARM) delivered earnings and revenue surprises of -24.32% and 12.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: CARM
• Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates

  DURECT (DRRX) delivered earnings and revenue surprises of 25% and 1.19%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: PSTV